Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: July 5, 2000
Last updated: February 8, 2013
Last verified: April 2003
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)